» Articles » PMID: 9177214

Peptides Isolated from HLA-Cw*0304 Confer Different Degrees of Protection from Natural Killer Cell-mediated Lysis

Overview
Specialty Science
Date 1997 Jun 10
PMID 9177214
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

HLA class I molecules bind peptides derived from proteins degraded in the cytoplasm and display them for surveillance by the immune system. The recognition of HLA class I molecules by natural killer (NK) cells generally inhibits the lytic process. To investigate the role of peptides in the interaction between HLA class I molecules and NK receptors, we first had to identify representative endogenous peptides. Individual peptides bound to HLA-Cw*0304 were isolated and sequenced by tandem mass spectrometry. These peptides ranged in length from 8 to 11 residues and shared an alanine at position 2 and a C-terminal leucine. The murine transporters associated with antigen processing (TAP)-deficient cell line RMA-S was transfected with HLA-Cw*0304 to test whether HLA molecules loaded with a single peptide could deliver the inhibitory signal to NK cells expressing p58.2, which is a killer cell inhibitory receptor known to interact with HLA molecules bearing the HLA-Cw3 public epitope. We found that, in the absence of exogenous peptides, the HLA-Cw*0304 transfectants were killed at levels comparable to untransfected RMA-S cells whereas protection from lysis required both HLA-Cw*0304 heavy chain expression and an exogenously added HLA-Cw*0304-binding peptide. Importantly, not only were HLA-Cw*0304-binding peptides required for protection, but the ability of individual peptides to provide protection differed widely. These studies indicate that the ability to distinguish between subsets of peptides may be a general feature of HLA class I recognition by NK cells.

Citing Articles

Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.

Chen S, Zhu H, Jounaidi Y Signal Transduct Target Ther. 2024; 9(1):302.

PMID: 39511139 PMC: 11544004. DOI: 10.1038/s41392-024-02005-w.


Identification of a Clade-Specific HLA-C*03:02 CTL Epitope GY9 Derived from the HIV-1 p17 Matrix Protein.

Kyobe S, Mwesigwa S, Nkurunungi G, Retshabile G, Egesa M, Katagirya E Int J Mol Sci. 2024; 25(17).

PMID: 39273630 PMC: 11395705. DOI: 10.3390/ijms25179683.


Conformational Alterations of the Cell Surface of Monomeric and Dimeric β2m-Free HLA-I (Proto-HLA) May Enable Novel Immune Functions in Health and Disease.

Ravindranath M, Ravindranath N, Amato-Menker C, Hilali F, Filippone E Curr Issues Mol Biol. 2024; 46(7):6961-6985.

PMID: 39057057 PMC: 11276036. DOI: 10.3390/cimb46070416.


beta-cell killing models using immune cells and human pluripotent stem cell-derived islets: Challenges and opportunities.

Halliez C, Ibrahim H, Otonkoski T, Mallone R Front Endocrinol (Lausanne). 2023; 13:1076683.

PMID: 36726462 PMC: 9885197. DOI: 10.3389/fendo.2022.1076683.


To Be or Not to Be: The Case of Endoplasmic Reticulum Aminopeptidase 2.

Kusnierczyk P Front Immunol. 2022; 13:902567.

PMID: 35769458 PMC: 9234130. DOI: 10.3389/fimmu.2022.902567.


References
1.
Malnati M, Lusso P, Ciccone E, Moretta A, Moretta L, Long E . Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements. J Exp Med. 1993; 178(3):961-9. PMC: 2191173. DOI: 10.1084/jem.178.3.961. View

2.
Littaua R, Oldstone M, Takeda A, Debouck C, Wong J, Tuazon C . An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. J Virol. 1991; 65(8):4051-6. PMC: 248836. DOI: 10.1128/JVI.65.8.4051-4056.1991. View

3.
Malnati M, Peruzzi M, Parker K, Biddison W, Ciccone E, Moretta A . Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science. 1995; 267(5200):1016-8. DOI: 10.1126/science.7863326. View

4.
Kurago Z, Smith K, Lutz C . NK cell recognition of MHC class I. NK cells are sensitive to peptide-binding groove and surface alpha-helical mutations that affect T cells. J Immunol. 1995; 154(6):2631-41. View

5.
Rammensee H, Friede T, Stevanoviic S . MHC ligands and peptide motifs: first listing. Immunogenetics. 1995; 41(4):178-228. DOI: 10.1007/BF00172063. View